How long do prepared epidural solutions remain sterile?

Journal of Pain and Symptom Management

Volumn 18, Issue 2, 1999, Pages 137-139

  McIntosh, Don ^a   Spaven, Joan ^a   Hagen, Neil A ^a,b  

^a TOM BAKER CANCER CENTRE   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Cancer pain; Infection; Quality assurance; Spinal analgesia

Indexed keywords

BUPIVACAINE; FENTANYL; MORPHINE; OPIATE;

ARTICLE; CANCER PAIN; DRUG SOLUTION; EPIDURAL CATHETER; EPIDURAL DRUG ADMINISTRATION; FREEZING; HUMAN; INFECTION; QUALITY CONTROL; SPINAL ANESTHESIA;

ANALGESIA, EPIDURAL; COLONY COUNT, MICROBIAL; HUMANS; QUALITY ASSURANCE, HEALTH CARE; SOLUTIONS; STERILIZATION; TIME FACTORS;

EID: 0032823001     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(99)00052-4     Document Type: Article

References (7)

1. Swarm RA, Cousins MJ. Anaesthetic techniques for pain control. In: Doyle D, Hank GWC, MacDonald N, eds. Oxford Textbook of Palliative Medicine. Oxford, Oxford University Press, 1994:204-221.
2. Litrell R.A. Epidural Analgesia. Am J Hosp Pharm. 48:1991;2460-2474.
3. Buchanan EC. Principles of sterile product preparation. Bethesda, MD. American Society of Health System Pharmacists 1995.
4. Du Pen S.L., Williams A.R. Management of patients receiving combined epidural morphine and bupivacaine for the treatment of cancer pain. J Pain Symptom Manage. 7:1992;125-127.
5. Du Pen S.L., Williams A.R. Spinal and peripheral drug delivery systems. Pain Digest. 5:1995;307-317.
6. Samuelsson H., Malmberg F., Eriksson M., Hedner T. Outcomes of epidural morphine treatment in cancer pain. nine years of clinical experience J Pain Symptom Manage. 10:1995;105-112.
7. Maki D.G., Boticelli J.T., LeRoy M.L., Thielke T.S. Prospective study of replacing administration sets for intravenous therapy at 48- vs. 72-hour intervals. J Am Med Assoc. 258:1987;1777-1781.